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Daptomycin-induced eosinophilic pneumonia
Figure 1. Initial chest X-ray (panel A) and CT scans (panels B and C) showing diffuse alveolar (asterisks) and interstitial (arrows) opacities. A follow-up X-ray showed
normalization at 3 weeks after daptomycin cessation (panel D).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j idA 67-year-old man presented a haematogenous methicillin-
susceptible Staphylococcus aureus hip prosthesis infection
with a severe local condition requiring implant removal. Lip
swelling after an oxacillin infusion (day 2) and vancomycin/
gentamicin-induced acute renal failure (day 3; glomerularhttp://dx.doi.org/10.1016/j.ijid.2015.06.010
1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).ﬁltration rate 30 ml/min) eventually led to a switch to
daptomycin (6 mg/kg/day) and ciproﬂoxacin. Following this
there was an improvement in renal function and blood cultures
became sterile. Seventeen days later, the patient presented a
dry cough with diffuse crackles on lung auscultation; he wasciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Medical Imagery / International Journal of Infectious Diseases 37 (2015) 95–9696hypoxemic (SpO2, 87%). A chest X-ray and computed tomogra-
phy (CT) scan revealed diffuse alveolar and interstitial opacities
(Figure 1). His blood eosinophil count increased to 2.6  109/l.
Bronchoalveolar lavage (BAL) ﬂuid analysis showed 10%
eosinophils, with 59% monocytes, 18% neutrophils, and 13%
lymphocytes. The plasma daptomycin trough concentration did
not indicate an overdose (23.1 mg/l). The patient improved over
the course of 4 days following the withdrawal of antimicrobials
and with the addition of intravenous methylprednisolone
(1 mg/kg/day), which was reduced progressively over 3 weeks.
At this time the chest X-ray ﬁndings normalized. Cefazolin and
rifampicin were started, allowing prosthesis reimplantation
6 weeks later. After 3 months, the treatment was ﬁnally stopped.
Daptomycin-induced acute eosinophilic pneumonia is a rare
but potentially severe adverse event usually occurring after 2–3
weeks.1,2 Bilateral pulmonary inﬁltrates and eosinophils of any
value in BAL ﬂuid are of diagnostic value.3 A prompt improvement
after daptomycin withdrawal is generally observed, with cortico-
steroid therapy sometimes required.2
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